ACS applied materials & interfaces · 2026
Differential Cytoskeletal Control of Cell-Collagen Mechanics in High- and Low-Flow Glaucomatous Trabecular Meshwork Cells.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Karimi Alireza, Golchin Hasti, Adamec Megan, Stanik Ansel, Nandakumar Pretham, Ganesan Mithran, Aga Mini, White Elizabeth, Kelley Mary J, Acott Ted
Аннотация
We quantified cytoskeletal regulation of cell-collagen mechanics in glaucomatous trabecular meshwork (TM) cells from tracer-identified high-flow (HF) and low-flow (LF) regions using 3D traction force microscopy coupled to collagen kinematics. Matched HF and LF cultures were derived from a single glaucomatous donor eye (n = 3 gels per condition per region) and seeded on fibrillar type I collagen gels (elastic modulus 27.7 kPa) containing 0.2 μm FluoSpheres. Cells were imaged hourly for 12 h after latrunculin B (0.5 μM), no codazole (1 μM), or withaferin A (2 μM), with region-matched vehicle controls. In controls, reconstructed mean traction increased from 4 to 12 h in both HF (36.2-44.8 kPa) and LF (23.6-40.6 kPa). Latrunculin B reduced traction early with partial recovery, while nocodazole timepoint means differed between HF and LF at 12 h (HF: 64.1 kPa, 3.96% strain; LF: 17.3 kPa, 0.98% strain) and shifted divergence toward convergence. Withaferin A reduced traction, strain, and curl at 12 h in both HF and LF and differed from control in LF collagen orientation angle dynamics (p = 0.021). Mixed-effects models with Bonferroni correction did not detect treatment-control differences in the rate of change over time for traction, strain, divergence, or curl after accounting for HF/LF; within LF, latrunculin B decreased divergence (p = 0.018) and withaferin A differed in strain change over time (p = 0.045). This segment-resolved assay supports comparative evaluation of cytoskeletal perturbations and motivates validation across additional donor-matched HF/LF pairs.